Phase 2/3 multi-center, double-blind, controlled trial comparing topical ARYS-01 (sorivudine) cream 3 percent, oral valaciclovir, and combination topical ARYS-01 cream /oral valaciclovir for treatment of herpes zoster in immunocompetent patients 18 years of age or older
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2008
At a glance
- Drugs Sorivudine; Valaciclovir
- Indications Herpes zoster
- Focus Therapeutic Use
- 06 Oct 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Apr 2008 New trial record.